Skip to content

Oracle acquires medical records firm Cerner in a $28 billion deal

Oracle acquires medical records firm Cerner in a $28 billion deal

Enterprise software firm Oracle (NYSE: ORCL) has acquired medical records company Cerner in an all-cash deal for $95 per share, or approximately $28.3 billion in equity value. 

In a press statement, Oracle chairman Larry Ellison stated [PDF] that the acquisition, which also ranks as the largest in its history, will help facilitate the firm’s presence in the health care sector by incorporating health data into its cloud services.

The transaction, which is expected to close in 2022 pending regulatory approvals, will see Cerner operate as a dedicated Industry Business Unit within Oracle. Generally, Cerner will be a crucial anchor of Oracle’s expected expansion into the healthcare sector. 

The companies stated that they intend to utilize resources on both sides to transform the health sector while gathering better information that can influence improved patient treatment outcomes.

Notably, the acquisition will integrate data that Cerner gathers with Oracle’s data analysis and artificial intelligence tools to highlight patterns and make predictions for effective treatments.

“With this acquisition, Oracle’s corporate mission expands to assume the responsibility to provide our overworked medical professionals with a new generation of easier-to-use digital tools that enable access to information via a hands-free voice interface to secure cloud applications,” said Ellison. 

Elsewhere, according to Cerner’s CEO, Dr David Feinberg, the acquisition would allow the medical records firm to continue modernizing electronic health data. 

Additionally, upon completion of the deal, Cerner will immediately integrate into Oracle’s earnings on a non-GAAP basis in the first full fiscal year after the closing date.

Software companies expanding into health care

Oracle now joins other leading software companies in expanding their footprint into the medical space. Recently, Microsoft reached a $16 billion deal to buy speech artificial intelligence company Nuance Communication. 

Overall, the technology and health sectors have led the 2021 M&A activity, which topped $5 trillion in 2021.

 

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.